A new implant is now in the clinical trial phase, and it grants a user the ability to use their brain to control their iPhone or iPad with their thoughts.
A stentrode | Credit: Synchron
The technology works similarly to other accessibility features, such as alternative switches. However, instead of registering a tap of a foot or a nod of the head, it registers the user's brain waves.
In an article by Semafor, spotted by 9to5Mac, we learn about Rodney Gorham, a retired software salesman in Australia.
Gorham has amyotrophic lateral sclerosis, or ALS, a nervous system disease that severely impacts physical function. He's also one of six people using a device called a "Synchron Switch."
Created by Synchron, the Synchron Switch works with an array of sensors inserted, known as the stentrode, into the brain via a blood vessel. The switch itself is controlled wirelessly from the patient's chest.
When Gorham thinks about tapping his foot, his iPad registers it as a finger tap on the screen.
Gorham can control his iPad with his Synchron Switch, allowing him to send single-word text messages.
"We're excited about iOS and Apple products because they're so ubiquitous," said Tom Oxley, Synchron's co-founder, and CEO. "And this would be the first brain switch input into the device."
Synchron is the first company to gain FDA approval, and the technology could be seen as a boon for patients with severe mobility limitations.